Publications by authors named "Louis Monnier"

Claim this Profile
S
Should glycaemic variability and times spent in levels 1 and 2 hypoglycaemia be revised downward in type 1 diabetes treated with advanced systems of insulin delivery?
Louis Monnier, Claude Colette, Pierre-Yves Benhamou, David Owens

Diabetes Obes Metab· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycemic variability and iatrogenic hypoglycemia: how to resolve.
Louis Monnier, Claude Colette, Eric Renard, Pierre-Yves Benhamou, Safa Aouinti

Diabetes Res Clin Pract· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevent hypoglycaemia when using automated insulin delivery systems in type 1 diabetes requires near normal glycaemic variability.
Louis Monnier, Claude Colette, Eric Renard, Pierre-Yves Benhamou, Safa Aouinti

Diabetes Metab· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Averaged glycaemic variability or by average: More than a simple question of wording.
Louis Monnier, Claude Colette, Fabrice Bonnet

Diabetes Metab· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Key indices of glycaemic variability for application in diabetes clinical practice.
Louis Monnier, Fabrice Bonnet, Claude Colette, Eric Renard, David Owens

Diabetes Metab· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three Key Indices in Clinical Practice to Better Comprehend the Postprandial and Basal Glucose Contributions in Type 2 Diabetes.
Louis Monnier, Claude Colette, David Owens

Diabetes Technol Ther· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Below Which Threshold of Glycemic Variability Is There a Minimal Risk of Hypoglycemia in People with Type 2 Diabetes?
Louis Monnier, Claude Colette, David Owens

Diabetes Technol Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Approaches for Emission Reduction in Industrial Plants Based on Physical Accounting: Example for an Aluminum Smelter.
Romain G Billy, Louis Monnier, Even Nybakke, Morten Isaksen, Daniel B Müller

Environ Sci Technol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin Centennial: Milestones influencing the development of insulin preparations since 1922.
David R Owens, Louis Monnier, Antonio Ceriello, Geremia B Bolli

Diabetes Obes Metab· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The obesity treatment dilemma: Why dieting is both the answer and the problem? A mechanistic overview.
Louis Monnier, Jean-Louis Schlienger, Claude Colette, Fabrice Bonnet

Diabetes Metab· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucose variability and diabetes complications: Risk factor or biomarker? Can we disentangle the "Gordian Knot"?
Louis Monnier, Claude Colette, David Owens

Diabetes Metab· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review of methods for detecting glycemic disorders.
Michael Bergman, Muhammad Abdul-Ghani, Ralph A DeFronzo, Melania Manco, Giorgio Sesti, Louis Monnier

Diabetes Res Clin Pract· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Respective Contributions of Glycemic Variability and Mean Daily Glucose as Predictors of Hypoglycemia in Type 1 Diabetes: Are They Equivalent?
Louis Monnier, Anne Wojtusciszyn, Nicolas Molinari, Claude Colette, Eric Renard

Diabetes Care· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on Echouffo-Tcheugui et al. Visit-to-Visit Glycemic Variability and Risks of Cardiovascular Events and All-Cause Mortality: The ALLHAT Study. Diabetes Care 2019;42:486-493.
Louis Monnier, Claude Colette, David Owens

Diabetes Care· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycaemic variability in diabetes: clinical and therapeutic implications.
Antonio Ceriello, Louis Monnier, David Owens

Lancet Diabetes Endocrinol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Branched-Chain Amino Acid Database Integrated in MEDIPAD Software as a Tool for Nutritional Investigation of Mediterranean Populations.
Sara Haydar, Thomas Paillot, Christophe Fagot, Yannick Cogne, Athanasios Fountas, Louis Monnier

Nutrients· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review of glucagon-like peptide-1 receptor agonists and their effects on lowering postprandial plasma glucose and cardiovascular outcomes in the treatment of type 2 diabetes mellitus.
David R Owens, Louis Monnier, Markolf Hanefeld

Diabetes Obes Metab· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of postprandial and fasting plasma glucose with HbA1c across the spectrum of glycaemic impairment in type 2 diabetes.
Paul Valensi, Lise Lotte N Husemoen, James Weatherall, Louis Monnier

Int J Clin Pract· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Future challenges and therapeutic opportunities in type 2 diabetes: Changing the paradigm of current therapy.
David R Owens, Louis Monnier, Anthony H Barnett

Diabetes Obes Metab· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes.
Louis Monnier, Claude Colette, Anne Wojtusciszyn, Sylvie Dejager, Eric Renard

Diabetes Care· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualized, patient-centered use of lixisenatide for the treatment of type 2 diabetes mellitus.
Markolf Hanefeld, Denis Raccah, Louis Monnier

Expert Opin Drug Metab Toxicol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on the FLAT-SUGAR Trial Investigators. Glucose Variability in a 26-Week Randomized Comparison of Mealtime Treatment With Rapid-Acting Insulin Versus GLP-1 Agonist in Participants With Type 2 Diabetes at High Cardiovascular Risk. Diabetes Care 2016;39:973-981.
Louis Monnier, Claude Colette, David R Owens

Diabetes Care· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular Trials.
Markolf Hanefeld, Louis Monnier, Oliver Schnell, David Owens

Diabetes Ther· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of HbA1c variability with atherosclerosis in diabetes: simple marker, risk factor or statistical bias?
Louis Monnier, Claude Colette

J Diabetes Complications· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Mild dysglycemia" in type 2 diabetes: to be neglected or not?
Louis Monnier, Claude Colette, Sylvie Dejager, David R Owens

J Diabetes Complications· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis